Popular Articles

Mar 09, 2017
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Facing mixed market signals, biotech companies look to rise above the fray in advancing new-wave discoveries to the clinical finish line.
Feb 01, 2017
Pharmaceutical Executive
With the push toward value-based heathcare set to accelerate even more in 2017, Takeda’s VP of global market access discusses the evolution of this all-important engine for medical innovation and bottom-line returns.
Dec 21, 2016
Pharmaceutical Executive
Cleveland Clinic looks at the big medical innovations in store for 2017.
Jul 26, 2016
Pharmaceutical Executive
Pharm Exec’s 16th annual listing of the top biopharma players points to important transitions taking place in the larger business model.
Mar 11, 2016
Pharmaceutical Executive
Positioning for success in biopharma requires a self-critical analysis of the risk and rewards among four categories of value differentiation. The key question: How do you define yourself against the competition?
Dec 20, 2015
Pharmaceutical Executive
The eight trends brought on by “once-and-done” interventions that may transform thinking around healthcare marketing.
Nov 24, 2015
Pharmaceutical Executive
Falling enterprise values and the drug pricing controversy have defined the life sciences landscape during the waning days of 2015. Casey McDonald reports.
Nov 09, 2015
Pharmaceutical Executive
Experts warn that if pharma doesn’t take a tighter grip on its supply chain and yank it into the 21st century, the industry could soon face distribution and logistics crises on an unprecedented scale.
Jul 30, 2015
Pharmaceutical Executive
This year’s Pharm Exec list of 17 leaders is ripe with the diversified backgrounds and skills required to advance to the “c-suite” in a new era of change for the industry.
Jul 15, 2015
By Pharmaceutical Executive Editors
A quick countdown of this year's Top 50 movers and shakers.
native1_300x100
lorem ipsum